Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

Summary

This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications